Published in Invest Ophthalmol Vis Sci on December 01, 2007
Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa. FASEB J (2009) 1.22
Insights into the mechanisms of macular degeneration associated with the R172W mutation in RDS. Hum Mol Genet (2014) 0.92
Biochemical analysis of phenotypic diversity associated with mutations in codon 244 of the retinal degeneration slow gene. Biochemistry (2010) 0.90
Gene therapy in the Retinal Degeneration Slow model of retinitis pigmentosa. Adv Exp Med Biol (2010) 0.78
PRPH2/RDS and ROM-1: Historical context, current views and future considerations. Prog Retin Eye Res (2016) 0.77
Structural characterization of the second intra-discal loop of the photoreceptor tetraspanin RDS. FEBS J (2012) 0.77
Gene therapy for PRPH2-associated ocular disease: challenges and prospects. Cold Spring Harb Perspect Med (2014) 0.75
The K153Del PRPH2 mutation differentially impacts photoreceptor structure and function. Hum Mol Genet (2016) 0.75
Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy. Nat Genet (1993) 3.62
Peripherin. A rim-specific membrane protein of rod outer segment discs. Invest Ophthalmol Vis Sci (1987) 3.14
Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat Med (1998) 2.66
Cone-like morphological, molecular, and electrophysiological features of the photoreceptors of the Nrl knockout mouse. Invest Ophthalmol Vis Sci (2005) 2.51
Localization of peripherin/rds in the disk membranes of cone and rod photoreceptors: relationship to disk membrane morphogenesis and retinal degeneration. J Cell Biol (1992) 2.17
The cGMP-gated channel and related glutamic acid-rich proteins interact with peripherin-2 at the rim region of rod photoreceptor disc membranes. J Biol Chem (2001) 2.15
The retinal degeneration slow (rds) gene product is a photoreceptor disc membrane-associated glycoprotein. Neuron (1991) 2.07
The relationship between opsin overexpression and photoreceptor degeneration. Invest Ophthalmol Vis Sci (2001) 1.98
Retention of function without normal disc morphogenesis occurs in cone but not rod photoreceptors. J Cell Biol (2006) 1.70
The C terminus of peripherin/rds participates in rod outer segment targeting and alignment of disk incisures. Mol Biol Cell (2004) 1.58
Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy. Proc Natl Acad Sci U S A (2000) 1.56
The effect of peripherin/rds haploinsufficiency on rod and cone photoreceptors. J Neurosci (1997) 1.51
The R172W mutation in peripherin/rds causes a cone-rod dystrophy in transgenic mice. Hum Mol Genet (2004) 1.48
RNA interference-mediated suppression and replacement of human rhodopsin in vivo. Am J Hum Genet (2007) 1.47
Complete rescue of photoreceptor dysplasia and degeneration in transgenic retinal degeneration slow (rds) mice. Neuron (1992) 1.40
Modulating expression of peripherin/rds in transgenic mice: critical levels and the effect of overexpression. Invest Ophthalmol Vis Sci (2004) 1.32
The Cys214-->Ser mutation in peripherin/rds causes a loss-of-function phenotype in transgenic mice. Biochem J (2005) 1.28
Fusion between retinal rod outer segment membranes and model membranes: a role for photoreceptor peripherin/rds. Biochemistry (1998) 1.26
The tetraspanin protein peripherin-2 forms a complex with melanoregulin, a putative membrane fusion regulator. Biochemistry (2007) 1.15
Asn244His mutation of the peripherin/RDS gene causing autosomal dominant cone-rod degeneration. Hum Mol Genet (1994) 1.14
Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery. Vision Res (2007) 1.12
Macular dystrophy associated with mutations at codon 172 in the human retinal degeneration slow gene. Ophthalmology (1994) 1.10
P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice. Invest Ophthalmol Vis Sci (2003) 1.10
Role of the second intradiscal loop of peripherin/rds in homo and hetero associations. Biochemistry (2005) 1.05
A novel Cys-214-Ser mutation in the peripherin/RDS gene in a Japanese family with autosomal dominant retinitis pigmentosa. Hum Genet (1993) 1.04
Clinical features of codon 172 RDS macular dystrophy: similar phenotype in 12 families. Arch Ophthalmol (1999) 1.02
Full characterization of the maculopathy associated with an Arg-172-Trp mutation in the RDS/peripherin gene. Ophthalmic Genet (1996) 0.98
Preferential silencing of a common dominant rhodopsin mutation does not inhibit retinal degeneration in a transgenic model. Mol Ther (2006) 0.97
Molecular characterization of the skate peripherin/rds gene: relationship to its orthologues and paralogues. Invest Ophthalmol Vis Sci (2003) 0.97
A soluble peripherin/Rds C-terminal polypeptide promotes membrane fusion and changes conformation upon membrane association. Exp Eye Res (2003) 0.96
Founder effect, seen in the British population, of the 172 peripherin/RDS mutation-and further refinement of genetic positioning of the peripherin/RDS gene. Am J Hum Genet (1998) 0.94
Expression and characterization of peripherin/rds-rom-1 complexes and mutants implicated in retinal degenerative diseases. Methods Enzymol (2000) 0.94
A novel mutation (Asn244Lys) in the peripherin/RDS gene causing autosomal dominant retinitis pigmentosa associated with bull's-eye maculopathy detected by nonradioisotopic SSCP. Genomics (1994) 0.92
Genetic supplementation of RDS alleviates a loss-of-function phenotype in C214S model of retinitis pigmentosa. Adv Exp Med Biol (2008) 0.90
Macular dystrophy associated with monogenic Arg172Trp mutation of the peripherin/RDS gene in a Japanese family. Retina (1995) 0.90
Fusion between retinal rod outer segment membranes and model membranes: functional assays and role for peripherin/rds. Methods Enzymol (2000) 0.89
Peripherin/rds fusogenic function correlates with subunit assembly. Exp Eye Res (2002) 0.83
Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest Ophthalmol Vis Sci (2004) 1.92
Efficient non-viral ocular gene transfer with compacted DNA nanoparticles. PLoS One (2006) 1.71
Retention of function without normal disc morphogenesis occurs in cone but not rod photoreceptors. J Cell Biol (2006) 1.70
Pudendal neuralgia. J Minim Invasive Gynecol (2010) 1.69
Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol Vis (2006) 1.49
The R172W mutation in peripherin/rds causes a cone-rod dystrophy in transgenic mice. Hum Mol Genet (2004) 1.48
Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy. Hum Mol Genet (2011) 1.47
Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol Vis (2006) 1.47
RPE65: role in the visual cycle, human retinal disease, and gene therapy. Ophthalmic Genet (2009) 1.39
A partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles. PLoS One (2009) 1.37
Modulating expression of peripherin/rds in transgenic mice: critical levels and the effect of overexpression. Invest Ophthalmol Vis Sci (2004) 1.32
Impaired cone function and cone degeneration resulting from CNGB3 deficiency: down-regulation of CNGA3 biosynthesis as a potential mechanism. Hum Mol Genet (2009) 1.30
The Cys214-->Ser mutation in peripherin/rds causes a loss-of-function phenotype in transgenic mice. Biochem J (2005) 1.28
Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa. FASEB J (2009) 1.22
Effect of Rds abundance on cone outer segment morphogenesis, photoreceptor gene expression, and outer limiting membrane integrity. J Comp Neurol (2007) 1.20
Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis. J Cell Sci (2007) 1.20
DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice. J Clin Invest (2012) 1.19
Retinal stem cells transplanted into models of late stages of retinitis pigmentosa preferentially adopt a glial or a retinal ganglion cell fate. Invest Ophthalmol Vis Sci (2007) 1.16
Lipid hydroperoxide formation in the retina: correlation with retinal degeneration and light damage in a rat model of Smith-Lemli-Opitz syndrome. Exp Eye Res (2005) 1.16
Differential requirements for retinal degeneration slow intermolecular disulfide-linked oligomerization in rods versus cones. Hum Mol Genet (2008) 1.15
Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome. J Lipid Res (2003) 1.14
Outer segment oligomerization of Rds: evidence from mouse models and subcellular fractionation. Biochemistry (2008) 1.12
Development and characterization of a hypomorphic Smith-Lemli-Opitz syndrome mouse model and efficacy of simvastatin therapy. Hum Mol Genet (2006) 1.11
P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice. Invest Ophthalmol Vis Sci (2003) 1.10
Lack of protein-tyrosine sulfation disrupts photoreceptor outer segment morphogenesis, retinal function and retinal anatomy. Eur J Neurosci (2010) 1.08
Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina. PLoS One (2009) 1.06
Evidence for a circadian rhythm of susceptibility to retinal light damage. Photochem Photobiol (2002) 1.06
Lipidomic analysis of the retina in a rat model of Smith-Lemli-Opitz syndrome: alterations in docosahexaenoic acid content of phospholipid molecular species. J Neurochem (2007) 1.06
Role of the second intradiscal loop of peripherin/rds in homo and hetero associations. Biochemistry (2005) 1.05
G-protein betagamma-complex is crucial for efficient signal amplification in vision. J Neurosci (2011) 1.05
The role of Rds in outer segment morphogenesis and human retinal disease. Ophthalmic Genet (2006) 1.04
Differences in RDS trafficking, assembly and function in cones versus rods: insights from studies of C150S-RDS. Hum Mol Genet (2010) 1.03
Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Exp Eye Res (2005) 1.03
Alterations in retinal rod outer segment fatty acids and light-damage susceptibility in P23H rats. Mol Vis (2002) 1.03
Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy. Invest Ophthalmol Vis Sci (2013) 1.02
Retinal abnormalities associated with the G90D mutation in opsin. J Comp Neurol (2004) 1.00
Deletion of the p85alpha regulatory subunit of phosphoinositide 3-kinase in cone photoreceptor cells results in cone photoreceptor degeneration. Invest Ophthalmol Vis Sci (2011) 1.00
Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome. J Lipid Res (2011) 0.99
Cholesterol-dependent association of caveolin-1 with the transducin alpha subunit in bovine photoreceptor rod outer segments: disruption by cyclodextrin and guanosine 5'-O-(3-thiotriphosphate). Biochemistry (2003) 0.99
Early-onset, slow progression of cone photoreceptor dysfunction and degeneration in CNG channel subunit CNGB3 deficiency. Invest Ophthalmol Vis Sci (2011) 0.98
Molecular characterization of the skate peripherin/rds gene: relationship to its orthologues and paralogues. Invest Ophthalmol Vis Sci (2003) 0.97
S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA. Hum Mol Genet (2013) 0.97
7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Biochim Biophys Acta (2012) 0.96
Nanoparticle-mediated gene transfer specific to retinal pigment epithelial cells. Biomaterials (2011) 0.96
Comparative analysis of DNA nanoparticles and AAVs for ocular gene delivery. PLoS One (2012) 0.96
Nanoparticles for retinal gene therapy. Prog Retin Eye Res (2010) 0.95
Onecut1 is essential for horizontal cell genesis and retinal integrity. J Neurosci (2013) 0.95
Loss of caveolin-1 impairs retinal function due to disturbance of subretinal microenvironment. J Biol Chem (2012) 0.93
Ion-current-based proteomic profiling of the retina in a rat model of Smith-Lemli-Opitz syndrome. Mol Cell Proteomics (2013) 0.93
A comparison of the behavior of cholesterol and selected derivatives in mixed sterol-phospholipid Langmuir monolayers: a fluorescence microscopy study. Chem Phys Lipids (2005) 0.93
Direct gene transfer with compacted DNA nanoparticles in retinal pigment epithelial cells: expression, repeat delivery and lack of toxicity. Nanomedicine (Lond) (2012) 0.93
Drug and gene delivery to the back of the eye: from bench to bedside. Invest Ophthalmol Vis Sci (2014) 0.93
Expression profiling after retinal detachment and reattachment: a possible role for aquaporin-0. Invest Ophthalmol Vis Sci (2008) 0.92
Defects in the outer limiting membrane are associated with rosette development in the Nrl-/- retina. PLoS One (2012) 0.92
Increased cone sensitivity to ABCA4 deficiency provides insight into macular vision loss in Stargardt's dystrophy. Biochim Biophys Acta (2011) 0.91
Genetic supplementation of RDS alleviates a loss-of-function phenotype in C214S model of retinitis pigmentosa. Adv Exp Med Biol (2008) 0.90
Biochemical analysis of phenotypic diversity associated with mutations in codon 244 of the retinal degeneration slow gene. Biochemistry (2010) 0.90
Rhodopsin: the functional significance of asn-linked glycosylation and other post-translational modifications. Ophthalmic Genet (2009) 0.90
Photodamage generates 7-keto- and 7-hydroxycholesterol in the rat retina via a free radical-mediated mechanism. Photochem Photobiol (2009) 0.89
Peroxisome deficiency causes a complex phenotype because of hepatic SREBP/Insig dysregulation associated with endoplasmic reticulum stress. J Biol Chem (2008) 0.89
Structural and functional relationships between photoreceptor tetraspanins and other superfamily members. Cell Mol Life Sci (2011) 0.88
Disturbed cholesterol homeostasis in a peroxisome-deficient PEX2 knockout mouse model. Mol Cell Biol (2004) 0.88
Differential distribution of proteins and lipids in detergent-resistant and detergent-soluble domains in rod outer segment plasma membranes and disks. J Neurochem (2007) 0.88
Absence of functional and structural abnormalities associated with expression of EGFP in the retina. Invest Ophthalmol Vis Sci (2004) 0.88
Alteration of retinal rod outer segment membrane fluidity in a rat model of Smith-Lemli-Opitz syndrome. J Lipid Res (2008) 0.88
Gene therapy for Stargardt disease associated with ABCA4 gene. Adv Exp Med Biol (2014) 0.87
Nonviral ocular gene therapy: assessment and future directions. Curr Opin Mol Ther (2008) 0.85
A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium. Biomaterials (2013) 0.85
Lipid differences in rod outer segment membranes of rats with P23H and S334ter opsin mutations. Mol Vis (2005) 0.84
Differential developmental deficits in retinal function in the absence of either protein tyrosine sulfotransferase-1 or -2. PLoS One (2012) 0.83
Persistence of non-viral vector mediated RPE65 expression: case for viability as a gene transfer therapy for RPE-based diseases. J Control Release (2013) 0.83
RDS in cones does not interact with the beta subunit of the cyclic nucleotide gated channel. Adv Exp Med Biol (2010) 0.82
Mouse models of human retinal disease caused by expression of mutant rhodopsin. A valuable tool for the assessment of novel gene therapies. Adv Exp Med Biol (2003) 0.81
CNGA3 deficiency affects cone synaptic terminal structure and function and leads to secondary rod dysfunction and degeneration. Invest Ophthalmol Vis Sci (2012) 0.81
Cfh genotype interacts with dietary glycemic index to modulate age-related macular degeneration-like features in mice. Invest Ophthalmol Vis Sci (2014) 0.80
AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects. Invest Ophthalmol Vis Sci (2011) 0.80
Synthesis and characterization of glycol chitosan DNA nanoparticles for retinal gene delivery. ChemMedChem (2013) 0.80
Fibulin 2, a tyrosine O-sulfated protein, is up-regulated following retinal detachment. J Biol Chem (2014) 0.80
Peroxisome deficiency-induced ER stress and SREBP-2 pathway activation in the liver of newborn PEX2 knock-out mice. Biochim Biophys Acta (2012) 0.80
A perspective on the role of the extracellular matrix in progressive retinal degenerative disorders. Invest Ophthalmol Vis Sci (2013) 0.80
Episomal maintenance of S/MAR-containing non-viral vectors for RPE-based diseases. Adv Exp Med Biol (2014) 0.79
Enzyme blockade: a nonradioactive method to determine the absolute rate of cholesterol synthesis in the brain. J Lipid Res (2004) 0.79
Hepatic isoprenoid metabolism in a rat model of Smith-Lemli-Opitz Syndrome. Lipids (2013) 0.79
A 350 bp region of the proximal promoter of Rds drives cell-type specific gene expression. Exp Eye Res (2010) 0.79
The function of oligomerization-incompetent RDS in rods. Adv Exp Med Biol (2010) 0.78
Gene therapy in the Retinal Degeneration Slow model of retinitis pigmentosa. Adv Exp Med Biol (2010) 0.78